The present study was designed to determine the molecular effects of rTMS on serum levels of mature BDNF, proBDNF and MMP-9 in poststroke patients with upper limb hemiparesis, and the relationship between serum biomarkers and functional evaluation of upper limb hemiparesis in patients after stroke. Here, MMP9 is linked to Stroke.